Rankings
▼
Calendar
HROW Q3 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
Q3 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$72M
+45.4% YoY
Gross Profit
$54M
75.3% margin
Operating Income
$15M
20.6% margin
Net Income
$1M
1.4% margin
EPS (Diluted)
$0.03
QoQ Revenue Growth
+12.4%
Cash Flow
Operating Cash Flow
$17M
Free Cash Flow
$16M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$363M
Total Liabilities
$316M
Stockholders' Equity
$47M
Cash & Equivalents
$74M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$72M
$49M
+45.4%
Gross Profit
$54M
$37M
+44.8%
Operating Income
$15M
$1M
+1016.4%
Net Income
$1M
-$4M
+124.2%
← FY 2025
All Quarters
Q4 2025 →